p53-mediated apoptotic signaling overcomes the resistance to oncolytic adenovirus in human osteosarcoma cells

被引：0
|
作者：
Hasel, Joe [1 ]
Sasaki, Tsuyoshi [1 ]
Tazawa, Hiroshi [2 ]
Hashimoto, Yuuri [3 ]
Kunisada, Toshiyuki [4 ]
Urata, Yasuo [5 ]
Ozaki, Toshifumi [1 ]
Fujiwara, Toshiyoshi [3 ]
机构：
[1] Okayama Univ, Depertment Orthoped Surg, Okayama 7008530, Japan
[2] Okayama Univ Hosp, Ctr Gene & Cell Therapy 3, Okayama, Japan
[3] Okayama Univ, Depertment Gastroenterol Surg, Okayama 7008530, Japan
[4] Okayama Univ, Grad Sch, Depertment Med Mat Musculoskeletal Reconstruct, Okayama 7008530, Japan
[5] Oncolys BioPharma Inc, Okayama, Japan
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-5651
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5651
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Dual Programmed Cell Death Pathways Induced by p53 Transactivation Overcome Resistance to Oncolytic Adenovirus in Human Osteosarcoma Cells
    Hasei, Joe
    Sasaki, Tsuyoshi
    Tazawa, Hiroshi
    Osaki, Shuhei
    Yamakawa, Yasuaki
    Kunisada, Toshiyuki
    Yoshida, Aki
    Hashimoto, Yuuri
    Onishi, Teppei
    Uno, Futoshi
    Kagawa, Shunsuke
    Urata, Yasuo
    Ozaki, Toshifumi
    Fujiwara, Toshiyoshi
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (03) : 314 - 325
  • [2] Treatment with a BH3 mimetic overcomes the resistance of latency III EBV (+) cells to p53-mediated apoptosis
    Pujals, A.
    Renouf, B.
    Robert, A.
    Chelouah, S.
    Hollville, E.
    Wiels, J.
    CELL DEATH & DISEASE, 2011, 2 : e184 - e184
  • [3] Treatment with a BH3 mimetic overcomes the resistance of latency III EBV (+) cells to p53-mediated apoptosis
    A Pujals
    B Renouf
    A Robert
    S Chelouah
    É Hollville
    J Wiels
    Cell Death & Disease, 2011, 2 : e184 - e184
  • [4] PACT cessation overcomes ovarian cancer cell chemoresistance to cisplatin by enhancing p53-mediated apoptotic pathway
    Yang, Xuemei
    Zhang, Qian
    Yang, Xiaofeng
    Zhao, Minyi
    Yang, Ting
    Yao, Anmei
    Tian, Xiaofei
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2019, 511 (04) : 719 - 724
  • [5] Elephant p53 (EP53) enhances and restores p53-mediated apoptosis in human and canine osteosarcoma
    Abegglen, Lisa M.
    Toruno, Cristhian
    Donovan, Lauren N.
    Robinson, Rosann
    Goldfeder, Mor
    Couldwell, Genevieve
    Kiso, Wendy K.
    Schmitt, Dennis L.
    Caulin, Aleah F.
    Maley, Carlo C.
    Schroeder, Avi
    Schiffman, Joshua D.
    CLINICAL CANCER RESEARCH, 2018, 24 (02) : 48 - 49
  • [6] Integral role of Noxa in p53-mediated apoptotic response
    Shibue, T
    Takeda, K
    Oda, E
    Tanaka, H
    Murasawa, H
    Takaoka, A
    Morishita, Y
    Akira, S
    Taniguchi, T
    Tanaka, N
    GENES & DEVELOPMENT, 2003, 17 (18) : 2233 - 2238
  • [7] Late resistance to adenoviral p53-mediated apoptosis caused by decreased expression of Coxsackie-adenovirus receptors in human lung cancer cells
    Tango, Y
    Taki, M
    Shirakiya, Y
    Ohtani, S
    Tokunaga, N
    Tsunemitsu, Y
    Kagawa, S
    Tani, T
    Tanaka, N
    Fujiwara, T
    CANCER SCIENCE, 2004, 95 (05): : 459 - 463
  • [8] Chk2 is dispensable for p53-mediated G1 arrest but is required for a latent p53-mediated apoptotic response
    Jack, MT
    Woo, RA
    Hirao, A
    Cheung, A
    Mak, TW
    Lee, PWK
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (15) : 9825 - 9829
  • [9] Amifostine impairs p53-mediated apoptosis of human myeloid leukemia cells
    Acosta, JC
    Richard, C
    Delgado, MD
    Horita, M
    Rizzo, MG
    Fernández-Luna, JL
    León, J
    MOLECULAR CANCER THERAPEUTICS, 2003, 2 (09) : 893 - 900
  • [10] The p53-mediated cell cycle regulation is a potential mechanism for emodin-suppressing osteosarcoma cells
    Zhang, Qian
    Hao, Shuli
    Wei, Guangyou
    Liu, Xiangyu
    Miao, Yang
    HELIYON, 2024, 10 (05)
12345